Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
BDRX: Biodexa Pharmaceuticals Plc Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
BDRX
The Story
BDRX
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-71.9%
Financially safe
Stretched
Debt / equity
0.01×
Interest coverage
-72.3×
Current ratio
2.03×
Biodexa Pharmaceuticals Plc
BDRX
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Biodexa Pharmaceuticals Plc
BDRX
NASDAQ
·
USD
·
Closed
$1.32
−10.81%
$1.32
−$0.16 (10.81%)
52W Range
1th
pctl
Volume
0.05×
avg
Mkt Cap
984869
USD
P/E
-0.0
TTM
Div Yield
–
ann
52W Range
1th
pctl
Volume
0.05×
avg
Market Cap
984869
USD
P/E Ratio
-0.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings